AUG 28, 2018 10:37 PM PDT

Alternative Therapy for Peripheral Artery Disease

WRITTEN BY: Nouran Amin

Image Credit: conehealth.com

To fight peripheral artery diseases (PAD), an “ailment affecting 8 million Americans”, researchers at LSU School of Veterinary Medicine have discovered two drugs found in red wine that may serve as an alternative treatment: resveratrol and quercetin.

These particular drugs hold beneficial effects on arterial cells, such as healing, without any adverse side effects commonly seen in PAD therapies. The researcher’s goal was to use drugs that do not pose a threat to cells but rather restrict them from growing and narrowing an artery. "Dr. Dugas discovered that these two drugs in combination worked well for that purpose," said Crisitna Sabliov, LSU Biological and Agricultural Engineering professor. "She found the right potion, but she wanted the drugs released over time, and for that, she needed a smart delivery system. To be able to do that, Assistant Research Professor Carlos Astete and myself loaded these drugs into a nanoparticle," says Sabliov. "Nanoparticles are really, really small -- only 100-200 nanometers (nm). In comparison, a hair is 70,000 nm thick."

Researchers will seek to develop a drug-coated balloon (DCB) therapy where red wine compounds are sprayed evenly on the outside of a balloon in a nanoparticle can adhere to vessel walls, releasing the compound and preventing the growth of cells and narrowing of vessels to allow blood. "The whole procedure takes only a few minutes, so we need to make sure the particles are released from the balloon very quickly," said Sabliov.

However, research is never simple: "We have some challenges because, number one, you want the drugs released over time," Sabliov said. "And number two, the two different chemicals have to be in the optimum ratio that she [Dugas] finds works best. If they have a positive charge, then they attach quickly to the cells. "The ratio must be 1:2 because that's the magic potion that will make the drugs effective. We didn't want the drugs to kill the cells. We just wanted them to prevent the cells from growing back."

Learn more about peripheral artery disease (PAD):

Source: Louisiana State University, Journal of Biomedical Materials

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Does Adderall Really Work for People without ADHD?
Adderall is a popular stimulant. Known to treat Attention Deficit Disorder (ADHD), those without the condition also use it to increase attention, focus and...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Injectable Hydrogel Found Safe for Heart Repair
The first successful in-human clinical trial of an injectable hydrogel that aims to repair heart damage and restore cardiac function was recently conducted...
NOV 19, 2019
Neuroscience
NOV 19, 2019
Can CRISPR Technology Treat Alzheimer's?
New drugs that seek to treat Alzheimer’s disease (AD) have a 99.6% failure rate. This makes it the only disease in the top 10 causes of death that ca...
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Drug Increases Survival Rates for Heart Failure Patients
Scientists have demonstrated in preclinical studies that a drug called ‘Aliskiren’ works by inhibiting the activity of an enzyme involved in bl...
NOV 19, 2019
Technology
NOV 19, 2019
New Encapsulation Technology
Research at the University of Waterloo has concluded new encapsulation technology that can offer an inexpensive, and effective method for coating liquid me...
NOV 19, 2019
Cancer
NOV 19, 2019
How caloric restriction mimetics might prove helpful for cancer treatments
The benefits of fasting have been known to scientists and medical professionals for some time now, however for many, the reality of fasting is not alluring...
Loading Comments...